Skip to Content

Methylprednisolone Acetate Injection

Last Updated: June 27, 2017
Status: Current

Methylprednisolone Acetate Injection

Products Affected - Description
  • Methylprednisolone acetate injection, Sandoz
    40 mg/mL, 1 mL vials, 1 count (NDC 00781-3131-71)
    40 mg/mL, 1 mL vials, 10 count (NDC 00781-3131-95)
    40 mg/mL, 10 mL vials, 1 count (NDC 00781-3136-70)
    80 mg/mL, 1 mL vials, 1 count (NDC 00781-3132-71)
    80 mg/mL, 1 mL vials, 10 count (NDC 00781-3132-95)
    80 mg/mL, 5 mL vials, 1 count (NDC 00781-3137-75)

Reason for the Shortage
    • Sandoz could not provide a reason for the shortage.
    • Pfizer had Depo-Medrol injection on a short-term shortage due to increased demand of Solu-Medrol.
    • Teva is not actively marketing methylprednisolone acetate.
Available Products
  • Depo-Medrol injection, Pfizer
    20 mg/mL, 5 mL vials, 1 count (NDC 00009-0274-01)

40 mg/mL, 1 mL vial, 1 count (NDC 00009-3073-01)
40 mg/mL, 1 mL vial, 25 count (NDC 00009-3073-03)
40 mg/mL, 5 mL vials, 1 count (NDC 00009-0280-02)
40 mg/mL, 5 mL vials, 25 count (NDC 00009-0280-51)
40 mg/mL, 10 mL vials, 1 count (NDC 00009-0280-03)
40 mg/mL, 10 mL vials, 25 count (NDC 00009-0280-52)
80 mg/mL, 1 mL vials, 1 count (NDC 00009-3475-01)
80 mg/mL, 1 mL vial, 25 count (NDC 00009-3475-03)
80 mg/mL 5 mL vials, 1 count (NDC 00009-0306-02)
80 mg/mL 5 mL vials, 25 count (NDC 00009-0306-12)

Estimated Resupply Dates

  • Sandoz has methylprednisolone acetate injection temporarily unavailable and the company cannot estimate a release date.

Implications for Patient Care

    • FDA closed New England Compounding Company in Massachusetts due to a fungal meningitis outbreak linked to methylprednisolone acetate injections compounded by this pharmacy.
    • All commercially available products contain a preservative such as myristyl gamma picolinium chloride or benzyl alcohol.
    • Methylprednisolone acetate is not approved for epidural administration and contraindicated for intrathecal use.

Updated

June 27, April 3, January 11, 2017; December 16, September 13, June 17 and 13, May 27, 16 and 10, March 2, 2016; December 15, September 25, August 12 and 4, June 15, April 30 and 7, March 20 and 4, February 2, January 9, 2015; December 12, October 10, September 22 and 5, August 28 and 13, July 31 and 15, June 30 and 19, April 24, March 17 and 11, February 3, January 15, 2014; November 14, September 26, August 22 and 6, July 23 and 16, May 3, April 19, March 15, January 22, 2013; November 20, September 26, August 21, July 26 and 9, June 20, May 22, 2012, University of Utah, Drug Information Service. Copyright 2017, Drug Information Service, University of Utah, Salt Lake City, UT.

Hide